Efficacy and safety of a lidocaine/tetracaine medicated patch or peel for dermatologic procedures: a meta-analysis

다국어 초록 (Multilingual Abstract)

Background: To justify the use of the lidocaine/tetracaine medicated patch or peel as a preventive treatment for reducing pain and discomfort in adults and children. We reviewed randomized controlled trials (RCTs) to evaluate the efficacy and safety of the lidocaine/tetracaine medicated patch or peel compared with placebo.
Methods: Ten RCTs (574 patients) were included in this systemic review. Relevant studies were identified through searches of MEDLINE, SCOPUS and the Cochrane database library. The outcome was the adequacy of cutaneous anesthesia reflected in the patient's assessment of pain intensity during minor dermatologic procedures and adverse effects after application of the lidocaine/tetracaine medicated patch or peel versus placebo.
Results: The efficacy of the lidocaine/tetracaine patch or peel was consistently very significantly beneficial 30 or 60 minutes after the application compared to placebo (Relative risk, RR: 2.5; Number needed to treat, NNT: 2.2). We did not identify any difference in the effectiveness of adequate analgesia between the lidocaine/tetracaine patch and peel (the number needed to treat or to harm, NNT 2.4 vs. 2.0). No serious side effects or adverse events were observed with the lidocaine/tetracaine medicated patch or peel and placebo. Minor skin reactions were transient and resolved without treatment (Odd ratio, OR: 1.4 and 95% confidence interval, CI: 0.9-2.1; NNT: 14.9).
Conclusions: The lidocaine/tetracaine medicated patch or peel is a well accepted, effective and safe method for minor dermatologic procedures based on pooled data of trials in terms of adequacy of cutaneous anesthesia and adverse effects.

다국어 초록 (Multilingual Abstract)

Background: To justify the use of the lidocaine/tetracaine medicated patch or peel as a preventive treatment for reducing pain and discomfort in adults and children. We reviewed randomized controlled trials (RCTs) to evaluate the efficacy and safety of the lidocaine/tetracaine medicated patch or peel compared with placebo.
Methods: Ten RCTs (574 patients) were included in this systemic review. Relevant studies were identified through searches of MEDLINE, SCOPUS and the Cochrane database library. The outcome was the adequacy of cutaneous anesthesia reflected in the patient's assessment of pain intensity during minor dermatologic procedures and adverse effects after application of the lidocaine/tetracaine medicated patch or peel versus placebo.
Results: The efficacy of the lidocaine/tetracaine patch or peel was consistently very significantly beneficial 30 or 60 minutes after the application compared to placebo (Relative risk, RR: 2.5; Number needed to treat, NNT: 2.2). We did not identify any difference in the effectiveness of adequate analgesia between the lidocaine/tetracaine patch and peel (the number needed to treat or to harm, NNT 2.4 vs. 2.0). No serious side effects or adverse events were observed with the lidocaine/tetracaine medicated patch or peel and placebo. Minor skin reactions were transient and resolved without treatment (Odd ratio, OR: 1.4 and 95% confidence interval, CI: 0.9-2.1; NNT: 14.9).
Conclusions: The lidocaine/tetracaine medicated patch or peel is a well accepted, effective and safe method for minor dermatologic procedures based on pooled data of trials in terms of adequacy of cutaneous anesthesia and adverse effects.

참고문헌 (Reference)

1 Singer AJ, "Warm lidocaine/ tetracaine patch versus placebo before pediatric intravenous cannulation: a randomized controlled trial" 52 : 41-47, 2008

2 Curry SE, "Use of the Synera patch for local anesthesia before vascular access procedures: a randomized, double-blind, placebo-controlled study" 8 : 497-502, 2007

3 Chen JZ, "Two randomized, double-blind, placebo-controlled studies evaluating the S-Caine Peel for induction of local anesthesia before long-pulsed Nd:YAG laser therapy for leg veins" 29 : 1012-1018, 2003

4 Houck CS, "Transdermal analgesia with local anesthetics in children: review, update and future directions" 5 : 625-634, 2005

5 Shainhouse T, "Topical anesthetics: physiology, formulations, and novel delivery systems" 2 : 89-99, 2004

6 Friedman PM, "Topical anesthetics update: EMLA and beyond" 27 : 1019-1026, 2001

7 Chen BK, "Topical anesthetics in children: agents and techniques that equally comfort patients, parents, and clinicians" 13 : 324-330, 2001

8 Eidelman A, "Topical anesthetics for dermal instrumentation: a systematic review of randomized, controlled trials" 46 : 343-351, 2005

9 Kaweski S, "Topical anesthetic creams" 121 : 2161-2165, 2008

10 Soltesz S, "Topical anesthesia before vascular access in children. Comparison of a warmth-producing lidocaine-tetracaine patch with a lidocaineprilocaine patch" 59 : 519-523, 2010

11 Doshi SN, "Thirty-minute application of the S-Caine peel prior to nonablative laser treatment" 29 : 1008-1011, 2003

12 Alster TS, "The lidocaine/tetracaine peel: a novel topical anesthetic for dermatologic procedures in adult patients" 33 : 1073-1081, 2007

13 Bryan HA, "The S-Caine peel: a novel topical anesthetic for cutaneous laser surgery" 28 : 999-1003, 2002

14 Berman B, "Self-warming lidocaine/tetracaine patch effectively and safely induces local anesthesia during minor dermatologic procedures" 31 : 135-138, 2005

15 Schecter AK, "Randomized, double-blind, placebo-controlled study evaluating the lidocaine/tetracaine patch for induction of local anesthesia prior to minor dermatologic procedures in geriatric patients" 31 : 287-291, 2005

16 Tadicherla S, "Percutaneous dermal drug delivery for local pain control" 2 : 99-113, 2006

17 Croxtall JD, "Lidocaine/tetracaine medicated plaster: in minor dermatological and needle puncture procedures" 70 : 2113-2120, 2010

18 Sawyer J, "Heated lidocaine/tetracaine patch (Synera, Rapydan) compared with lidocaine/prilocaine cream (EMLA) for topical anaesthesia before vascular access" 102 : 210-215, 2009

19 Chen JZ, "Evaluation of the S-Caine Peel for induction of local anesthesia for laser-assisted tattoo removal: randomized, doubleblind, placebo-controlled, multicenter study" 31 : 281-286, 2005

20 Alster TS, "Evaluation of a novel topical anesthetic agent for cutaneous laser resurfacing: a randomized comparison study" 28 : 1004-1006, 2002

21 Shomaker TS, "Evaluating skin anesthesia after administration of a local anesthetic system consisting of an S-Caine patch and a controlled heat-aided drug delivery (CHADD) patch in volunteers" 16 : 200-204, 2000

22 Bax L, "Development and validation of MIX: comprehensive free software for meta-analysis of causal research data" 6 : 50-, 2006

23 Masud S, "Contribution of a heating element to topical anesthesia patch efficacy prior to vascular access: results from two randomized, double-blind studies" 40 : 510-519, 2010

24 George RB, "Brief report: a randomized controlled trial of Synera versus lidocaine for epidural needle insertion in labouring parturients" 55 : 168-171, 2008

25 Jadad AR, "Assessing the quality of reports of randomized clinical trials: is blinding necessary?" 17 : 1-12, 1996

26 Bax L, "A systematic comparison of software dedicated to meta-analysis of causal studies" 7 : 40-, 2007

27 Sethna NF, "A randomized controlled trial to evaluate S-Caine patch for reducing pain associated with vascular access in children" 102 : 403-408, 2005

28 Jih MH, "60-minute application of S-Caine Peel prior to 1,064 nm long-pulsed Nd:YAG laser treatment of leg veins" 34 : 446-450, 2004